Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first episode and first recurrence: a study protocol for a randomised, controlled, open-label, multicentre phase III clinical trial.
- DOI
- 10.1136/bmjopen-2026-119480
- Published
- 2026 Aug 28
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2026-119480,
title = {Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first episode and first recurrence: a study protocol for a randomised, controlled, open-label, multicentre phase III clinical trial.},
author = {Galpérine T and Erard V and Sommerstein R and Albricht WC and Papadimitriou-Olivgeris M and Gubler M and Brugger SD and Tschudin-Sutter S and Moser M and Cagnon L and Ballif A and Becker D and Moser K and Guery B},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2026-119480},
url = {https://doi.org/10.1136/bmjopen-2026-119480}
}RIS
TY - JOUR TI - Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first episode and first recurrence: a study protocol for a randomised, controlled, open-label, multicentre phase III clinical trial. AU - Galpérine T AU - Erard V AU - Sommerstein R AU - Albricht WC AU - Papadimitriou-Olivgeris M AU - Gubler M AU - Brugger SD AU - Tschudin-Sutter S AU - Moser M AU - Cagnon L AU - Ballif A AU - Becker D AU - Moser K AU - Guery B PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2026-119480 UR - https://doi.org/10.1136/bmjopen-2026-119480 ER -
APA
T, G., V, E., R, S., WC, A., M, P., M, G., SD, B., S, T., M, M., L, C., A, B., D, B., K, M., & B, G. (2026). Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first episode and first recurrence: a study protocol for a randomised, controlled, open-label, multicentre phase III clinical trial.. BMJ open. https://doi.org/10.1136/bmjopen-2026-119480
Source records
- pubmed · retrieved 2026-09-25T20:27:21.745Z